The NHS has been banned from attempting to save money by enforcing minimum waiting times for patients following referrals.

The government has been ordered to publish a report it attempted to keep secret that details the risks of its NHS reforms.

Ageas Protect has overhauled its critical illness (CI) product to include15 ABI+ condition definitions and extended its relationship with Best Doctors.

The Work and Pensions Secretary has vowed that employment and support allowance (ESA) claimants appealing their ineligibility decision will not have their benefit payments stopped.

The National Institute for Health and Clinical Excellence (Nice) has banned another breast cancer drug from routine NHS use.

Zurich has urged advisers to be prepared for the impact of gender neutrality on their clients and business.

For those seeking a break from the norm, Owain Thomas discovers the IPMI market is both growing strongly and increasingly dynamic

Almost £300m was paid out in group income protection (GIP) claims last year according to figures collated by Grid.

Ageas Protect has seen its protection business almost double over the first three quarters of the year although it is yet to reach profitability.

Group protection business at Friends Life dropped by more than half in the third quarter of the year while individual business slipped slightly compared to the previous three months.